---
title: Liraglutide for Children 6 to &lt;12 Years of Age with Obesity - A Randomized
  Trial
date: '2024-09-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39258838/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240911183636&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Among children (6 to <12 years of age) with obesity, treatment
  with liraglutide for 56 weeks plus lifestyle interventions resulted in a greater
  reduction in BMI than placebo plus lifestyle interventions. (Funded by Novo Nordisk;
  SCALE Kids ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Among children (6 to <12 years of age) with obesity, treatment with liraglutide for 56 weeks plus lifestyle interventions resulted in a greater reduction in BMI than placebo plus lifestyle interventions. (Funded by Novo Nordisk; SCALE Kids ClinicalTrials.gov number, ...